| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.72 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |